| Ident. | Authors (with country if any) | Title |
|---|
| 000E79 (2017) |
Leslie A. Reperant [Pays-Bas] ; Albert D. M. E. Osterhaus [Pays-Bas, Allemagne] | AIDS, Avian flu, SARS, MERS, Ebola, Zika… what next? |
| 001786 (2014) |
Christopher M. Coleman [États-Unis] ; Ye V. Liu [États-Unis] ; HAIYAN MU [États-Unis] ; Justin K. Taylor [États-Unis] ; Michael Massare [États-Unis] ; David C. Flyer [États-Unis] ; Gregory M. Glenn [États-Unis] ; Gale E. Smith [États-Unis] ; Matthew B. Frieman [États-Unis] | Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice |
| 002027 (2011) |
Kai Zhao ; Hui Wang ; Changyou Wu | The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848 |
| 002353 (2011) |
KAI ZHAO [République populaire de Chine] ; HUI WANG [République populaire de Chine] ; CHANGYOU WU [République populaire de Chine] | The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, Polyl:C and R848 |
| 002385 (2011) |
Ye V. Liu [États-Unis] ; Michael J. Massare [États-Unis] ; Dale L. Barnard [États-Unis] ; Thomas Kort [États-Unis] ; Margret Nathan [États-Unis] ; LEI WANG [États-Unis] ; Gale Smith [États-Unis] | Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV |
| 002946 (2010) |
KAI ZHAO [République populaire de Chine] ; BINYAN YANG [République populaire de Chine] ; YANQUAN XU [République populaire de Chine] ; CHANGYOU WU [République populaire de Chine] | CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein |
| 002B45 (2009) |
Joshua M. Dinapoli [États-Unis] ; Jerrold M. Ward ; Lily Cheng ; Lijuan Yang ; Subbiah Elankumaran ; Brian R. Murphy ; Siba K. Samal ; Peter L. Collins ; Alexander Bukreyev | Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. |
| 002B61 (2009) |
Hui Hu [République populaire de Chine] ; Xianqing Huang [République populaire de Chine] ; Ling Tao [République populaire de Chine] ; Yi Huang [République populaire de Chine] ; Bao-An Cui [République populaire de Chine] ; Hanzhong Wang [République populaire de Chine] | Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model |
| 002B71 (2009) |
Nuoyan Zheng [République populaire de Chine] ; Ran Xia [République populaire de Chine] ; Cuiping Yang [République populaire de Chine] ; Bojiao Yin [République populaire de Chine] ; Yin Li [République populaire de Chine] ; Chengguo Duan [République populaire de Chine] ; Liming Liang [République populaire de Chine] ; Huishan Guo [République populaire de Chine] ; Qi Xie [République populaire de Chine] | Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice |
| 002F03 (2009) |
Satoshi Ohno [Japon] ; Shunsuke Kohyama [Japon] ; Maiko Taneichi [Japon] ; Osamu Moriya [Japon] ; Hidenori Hayashi [Japon] ; Hiroshi Oda [Japon] ; Masahito Mori [Japon] ; Akiharu Kobayashi [Japon] ; Toshitalca Akatsuka [Japon] ; Tetsuya Uchida [Japon] ; Masanori Matsui [Japon] | Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice |
| 002F41 (2009) |
HUI HU [République populaire de Chine] ; XIANQING HUANG [République populaire de Chine] ; LING TAO [République populaire de Chine] ; YI HUANG [République populaire de Chine] ; Bao-An Cui [République populaire de Chine] ; HANZHONG WANG [République populaire de Chine] | Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model |
| 002F44 (2009) |
NUOYAN ZHENG [République populaire de Chine] ; RAN XIA [République populaire de Chine] ; CUIPING YANG [République populaire de Chine] ; BOJIAO YIN [République populaire de Chine] ; YIN LI [République populaire de Chine] ; CHENGGUO DUAN [République populaire de Chine] ; LIMING LIANG [République populaire de Chine] ; HUISHAN GUO [République populaire de Chine] ; QI XIE [République populaire de Chine] | Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice |
| 003054 (2008) |
Lanying Du [République populaire de Chine] ; Guangyu Zhao ; Yongping Lin ; Chris Chan ; Yuxian He ; Shibo Jiang ; Changyou Wu ; Dong-Yan Jin ; Kwok-Yung Yuen ; Yusen Zhou ; Bo-Jian Zheng | Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. |
| 003147 (2008) |
Kumari G. Lokugamage [États-Unis] ; Naoko Yoshikawa-Iwata ; Naoto Ito ; Douglas M. Watts ; Philip R. Wyde ; Nan Wang ; Patrick Newman ; Chien-Te Kent Tseng ; C J Peters ; Shinji Makino | Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV. |
| 003479 (2008) |
LANYING DU [Hong Kong, États-Unis] ; GUANGYU ZHAO [République populaire de Chine] ; YONGPING LIN [Hong Kong] ; CHRIS CHAN [Hong Kong] ; YUXIAN HE [États-Unis] ; SHIBO JIANG [États-Unis] ; CHANGYOU WU [République populaire de Chine] ; Dong-Yan Jin [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; YUSEN ZHOU [République populaire de Chine] ; Bo-Jian Zheng [Hong Kong] | Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection |
| 003494 (2008) |
Matthias Liniger [Suisse] ; Armando Zuniga [Suisse] ; Azaibi Tamin [États-Unis] ; Teldja N. Azzouz-Morin [Suisse] ; Marlyse Knuchel [Suisse] ; Rene R. Marty [Suisse] ; Marian Wiegand [Suisse] ; Sara Weibel [Suisse] ; David Kelvin [Canada] ; Paul A. Rota [États-Unis] ; Hussein Y. Naim [Suisse] | Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses |
| 003502 (2008) |
Girish J. Kotwal [États-Unis, Afrique du Sud] | Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs) |
| 003516 (2008) |
Enid T. Mckinley [États-Unis] ; Deborah A. Hilt [États-Unis] ; Mark W. Jackwood [États-Unis] | Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination |
| 003521 (2008) |
Kai Schulze [Allemagne] ; Caroline Staib [Allemagne] ; Hermann M. Sch Tzl [Allemagne] ; Thomas Ebensen [Allemagne] ; Volker Erfle [Allemagne] ; Carlos A. Guzman [Allemagne] | A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus |
| 003523 (2008) |
Julie E. Martin [États-Unis] ; Mark K. Louder [États-Unis] ; Lasonji A. Holman [États-Unis] ; Ingelise J. Gordon [États-Unis] ; Mary E. Enama [États-Unis] ; Brenda D. Larkin [États-Unis] ; Charla A. Andrews [États-Unis] ; Leatrice Vogel [États-Unis] ; Richard A. Koup [États-Unis] ; Mario Roederer [États-Unis] ; Robert T. Bailer [États-Unis] ; Phillip L. Gomez [États-Unis] ; Martha Nason [États-Unis] ; John R. Mascola [États-Unis] ; Gary J. Nabel [États-Unis] ; Barney S. Graham [États-Unis] | A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial |
| 003630 (2007) |
Jun Huang [République populaire de Chine] ; Yingnan Cao ; Jiali Du ; Xianzhang Bu ; Rui Ma ; Changyou Wu | Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. |
